Biosyntrx’s BioTears Dry Eye Formulation Awarded US Patent
April 28th, 2006
Nutrients included in the BioTears oral formulation have been suggested in clinical studies to systemically control the inflammatory process associated with dry eye syndrome (tear film dysfunction).
Original post by Glenn Hagele – USAEyes – glenn.hagele@usaeyes.org
(click on the author/publication link above to see full post)
